Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Does low intensity extracorporeal shock wave therapy have a physiological effect on erectile function? Short-term results of a randomized, double-blind, sham controlled study.

Vardi Y, Appel B, Kilchevsky A, Gruenwald I.

J Urol. 2012 May;187(5):1769-75. doi: 10.1016/j.juro.2011.12.117. Epub 2012 Mar 15.

PMID:
22425129
2.

Penile Low Intensity Shock Wave Treatment is Able to Shift PDE5i Nonresponders to Responders: A Double-Blind, Sham Controlled Study.

Kitrey ND, Gruenwald I, Appel B, Shechter A, Massarwa O, Vardi Y.

J Urol. 2016 May;195(5):1550-5. doi: 10.1016/j.juro.2015.12.049. Epub 2015 Dec 13.

PMID:
26694904
3.

Low intensity extracorporeal shockwave therapy for erectile dysfunction: a study in an Indian population.

Srini VS, Reddy RK, Shultz T, Denes B.

Can J Urol. 2015 Feb;22(1):7614-22.

PMID:
25694008
4.

Extracorporeal shockwave therapy in the treatment of erectile dysfunction: a prospective, randomized, double-blinded, placebo controlled study.

Yee CH, Chan ES, Hou SS, Ng CF.

Int J Urol. 2014 Oct;21(10):1041-5. doi: 10.1111/iju.12506. Epub 2014 Jun 17.

5.

Low-intensity extracorporeal shock wave therapy--a novel effective treatment for erectile dysfunction in severe ED patients who respond poorly to PDE5 inhibitor therapy.

Gruenwald I, Appel B, Vardi Y.

J Sex Med. 2012 Jan;9(1):259-64. doi: 10.1111/j.1743-6109.2011.02498.x. Epub 2011 Oct 18.

PMID:
22008059
6.

Impact of aging and comorbidity on the efficacy of low-intensity shock wave therapy for erectile dysfunction.

Hisasue S, China T, Horiuchi A, Kimura M, Saito K, Isotani S, Ide H, Muto S, Yamaguchi R, Horie S.

Int J Urol. 2016 Jan;23(1):80-4. doi: 10.1111/iju.12955. Epub 2015 Oct 26.

7.

Tadalafil once daily and extracorporeal shock wave therapy in the management of patients with Peyronie's disease and erectile dysfunction: results from a prospective randomized trial.

Palmieri A, Imbimbo C, Creta M, Verze P, Fusco F, Mirone V.

Int J Androl. 2012 Apr;35(2):190-5. doi: 10.1111/j.1365-2605.2011.01226.x. Epub 2011 Nov 15.

PMID:
22085227
8.

Can low-intensity extracorporeal shockwave therapy improve erectile dysfunction? A prospective, randomized, double-blind, placebo-controlled study.

Olsen AB, Persiani M, Boie S, Hanna M, Lund L.

Scand J Urol. 2015;49(4):329-33. doi: 10.3109/21681805.2014.984326. Epub 2014 Dec 3.

PMID:
25470423
10.

Spotlight on vardenafil in erectile dysfunction.

Keating GM, Scott LJ.

Drugs Aging. 2004;21(2):135-40. Review.

PMID:
14960129
11.

Effect of Low-Energy Linear Shockwave Therapy on Erectile Dysfunction-A Double-Blinded, Sham-Controlled, Randomized Clinical Trial.

Fojecki GL, Tiessen S, Osther PJ.

J Sex Med. 2017 Jan;14(1):106-112. doi: 10.1016/j.jsxm.2016.11.307. Epub 2016 Dec 6.

12.

Erection hardness: a unifying factor for defining response in the treatment of erectile dysfunction.

Mulhall JP, Levine LA, Jünemann KP.

Urology. 2006 Sep;68(3 Suppl):17-25. Review.

PMID:
17011372
14.

Vardenafil: a review of its use in erectile dysfunction.

Keating GM, Scott LJ.

Drugs. 2003;63(23):2673-703. Review.

PMID:
14636086
15.
16.

Improvement in duration of erection following phosphodiesterase type 5 inhibitor therapy with vardenafil in men with erectile dysfunction: the ENDURANCE study.

Rosenberg MT, Adams PL, McBride TA, Roberts JN, McCallum SW.

Int J Clin Pract. 2009 Jan;63(1):27-34. doi: 10.1111/j.1742-1241.2008.01947.x.

17.

Efficacy and safety of tadalafil in a Western European population of men with erectile dysfunction.

Eardley I, Gentile V, Austoni E, Hackett G, Lembo D, Wang C, Beardsworth A.

BJU Int. 2004 Oct;94(6):871-7.

18.

Effect of chronic sildenafil treatment on penile endothelial function: a randomized, double-blind, placebo controlled study.

Vardi Y, Appel B, Ofer Y, Greunwald I, Dayan L, Jacob G.

J Urol. 2009 Dec;182(6):2850-5. doi: 10.1016/j.juro.2009.08.025. Epub 2009 Oct 17.

PMID:
19837434
19.

Tadalafil in the treatment of erectile dysfunction following bilateral nerve sparing radical retropubic prostatectomy: a randomized, double-blind, placebo controlled trial.

Montorsi F, Nathan HP, McCullough A, Brock GB, Broderick G, Ahuja S, Whitaker S, Hoover A, Novack D, Murphy A, Varanese L.

J Urol. 2004 Sep;172(3):1036-41. Erratum in: J Urol. 2005 Feb;173(2):664.

PMID:
15311032

Supplemental Content

Support Center